César Serrano

4.1k citations
107 papers · 2.3k · 1 hit paper · h-index 24

Impact in

Papers in

César Serrano

94 papers receiving 2.2k citations

César Serrano's Hit Papers

Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial 2020 · 265 citations
2650+2+4Years since publication50100150200250

Peers

César Serrano
Comparison fields: 5 of 79
  • Gastroenterology 1.1k
  • Pulmonary and Respiratory Medicine 947
  • Obstetrics and Gynecology 195
  • Neurology 265
  • Oncology 351
Replace J. Buesa with:
J. Buesa Spain
Bernadette Liegl‐Atzwanger Austria
Yuji Sakuma Japan
Rodrigo Ruiz‐Soto United States
Arthur P. Staddon United States
Daniel A. Rushing United States
Agnès Neuville France
Javier Martínez‐Trufero Spain
Chiara Colombo Italy
Charles Forscher United States
César Serrano relative to J. Buesa Spain J. Buesa's profile →
Citations per field
00.5×10×20×31×
J. Buesa · 1×
Citations per year

Countries citing papers authored by César Serrano

Since Specialization
Citations

This map shows the geographic impact of César Serrano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by César Serrano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites César Serrano more than expected).

Fields of papers citing papers by César Serrano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by César Serrano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by César Serrano. The network helps show where César Serrano may publish in the future.

Co-authors

The 25 scholars most cited alongside César Serrano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with César Serrano Line = papers co-authored together César Serrano links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 107 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial
Hit paper breakdown →
2020265
2 2017164
3 2014154
4 2014128
5 2019123
6 2011121
7 2017106
8 2013101
9 202189
10 202076
11 201452
12 202351
13 201943
14 201442
15 201241
16 201540
17 202136
18 202134
19 201733
20 202131

About César Serrano

César Serrano is a scholar working on Gastroenterology, Pulmonary and Respiratory Medicine, Surgery, Oncology and Hematology, having authored 107 papers that have together received 2.3k indexed citations. Recurring topics across this work include Gastrointestinal Tumor Research and Treatment (74 papers), Sarcoma Diagnosis and Treatment (37 papers), Gastric Cancer Management and Outcomes (28 papers), Gastrointestinal disorders and treatments (12 papers), Platelet Disorders and Treatments (11 papers), Neurofibromatosis and Schwannoma Cases (8 papers), Cancer Genomics and Diagnostics (5 papers) and Bladder and Urothelial Cancer Treatments (5 papers). The work is most often cited by research in Gastroenterology (1.1k citations), Pulmonary and Respiratory Medicine (947 citations), Obstetrics and Gynecology (195 citations), Neurology (265 citations) and Oncology (351 citations). César Serrano has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Suzanne George, Sebastian Bauer, Michael C. Heinrich, Martee L. Hensley, Isabelle Ray‐Coquard, Claudia Valverde, Robin L. Jones, Patrick Schöffski, Margaret von Mehren and Jean‐Yves Blay. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, Therapeutic Advances in Medical Oncology and Clinical & Translational Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact